Anti-epileptic drugs and hepatitis C therapy: Real-world experience
Abstract
The latest update of the EASL recommendations for HCV treatment provides invaluable information to guide attempts at achieving the WHO goal of elimination.1 Direct-acting antivirals (DAAs) have significantly improved treatment of HCV infection, and almost all patients receiving these drugs achieve sustained virological response (SVR). However, there is still a niche of individuals with HCV who cannot be treated because of drug-drug interactions...
Paper Details
Title
Anti-epileptic drugs and hepatitis C therapy: Real-world experience
Published Date
Oct 1, 2021
Journal
Volume
75
Issue
4
Pages
984 - 985
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History